Report Overview
Anti-dementia drugs are a class of drugs used to slow down or improve cognitive dysfunction associated with dementia. Dementia is a chronic, progressive neurodegenerative disease characterized by a gradual decline in memory, thinking ability, language ability, and executive function, and is common in Alzheimer's disease, vascular dementia, Lewy body dementia, etc. The global Anti-dementia Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the ?Anti-dementia Drugs Industry Forecast? looks at past sales and reviews total world Anti-dementia Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected Anti-dementia Drugs sales for 2024 through 2030. With Anti-dementia Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-dementia Drugs industry. This Insight Report provides a comprehensive analysis of the global Anti-dementia Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-dementia Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Anti-dementia Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-dementia Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-dementia Drugs. United States market for Anti-dementia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. China market for Anti-dementia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Europe market for Anti-dementia Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Global key Anti-dementia Drugs players cover Jiangsu Hausen Pharmaceutical Group Co., Ltd., Zhien Biotechnology Co., Ltd., Zhejiang Huahai Pharmaceutical Co., Ltd., Jinri Pharmaceutical (China) Co., Ltd., Shandong Luoxin Pharmaceutical Group Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023. This report presents a comprehensive overview, market shares, and growth opportunities of Anti-dementia Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Donepezil Galantamine Rivastigmine Memantine Other Segmentation by Application: Hospital Clinic Pharmacy Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Zhien Biotechnology Co., Ltd. Zhejiang Huahai Pharmaceutical Co., Ltd. Jinri Pharmaceutical (China) Co., Ltd. Shandong Luoxin Pharmaceutical Group Co., Ltd. Chengdu Tongde Pharmaceutical Co., Ltd. Disa Pharmaceutical Group Co., Ltd. Zhejiang Hisun Pharmaceutical Co., Ltd. Zhejiang Yixin Pharmaceutical Co., Ltd. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Livzon Group Livzon Pharmaceutical Factory Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Yueyang Xinhuada Pharmaceutical Co., Ltd. Anhui Taienkang Pharmaceutical Co., Ltd. Zhejiang Jingxin Pharmaceutical Co., Ltd. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Sichuan Xinston Pharmaceutical Co., Ltd. Shaoxing Jingxin Pharmaceutical Co., Ltd. Niksan Pharmaceutical Pfizer Inc Eisai Inc. Reddy's Laboratories Forest Laboratories, Inc Key Questions Addressed in this Report What is the 10-year outlook for the global Anti-dementia Drugs market? What factors are driving Anti-dementia Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Anti-dementia Drugs market opportunities vary by end market size? How does Anti-dementia Drugs break out by Type, by Application?
Table Of Contents
Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2017-2029) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Anti-dementia Drugs Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Anti-dementia Drugs Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Anti-dementia Drugs Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by region) 5 Global Anti-dementia Drugs Market-Segmentation by Type 5.1 Type 1 5.2 Type 2 5.3 Type 3 6 Global Anti-dementia Drugs Market-Segmentation by Application 6.1 Application 1 6.2 Application 2 6.3 Application 3 7 Global Anti-dementia Drugs Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence A Company Profiles 8.1 Company 1 8.1.1 Company 1 Profile 8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023 8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis 8.1.4 Company 1 Business Overview/Recent Development/Acquisitions 8.2 Company 2 8.2.1 Company 2 Profile 8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023 8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis 8.2.4 Company 2 Business Overview/Recent Development/Acquisitions 8.3 Company 3 8.3.1 Company 3 Profile 8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023 8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis 8.3.4 Company 3 Business Overview/Recent Development/Acquisitions 8.4 Company 4 8.4.1 Company 4 Profile 8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023 8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis 8.4.4 Company 4 Business Overview/Recent Development/Acquisitions 8.5 Company 5 8.5.1 Company 5 Profile 8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023 8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis 8.5.4 Company 5 Business Overview/Recent Development/Acquisitions 8.6 Company 6 8.6.1 Company 6 Profile 8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023 8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis 8.6.4 Company 6 Business Overview/Recent Development/Acquisitions 8.7 Company 7 8.7.1 Company 7 Profile 8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023 8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis 8.7.4 Company 7 Business Overview/Recent Development/Acquisitions 8.8 Company 8 8.8.1 Company 8 Profile 8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023 8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis 8.8.4 Company 8 Business Overview/Recent Development/Acquisitions 8.9 Company 9 8.9.1 Company 9 Profile 8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023 8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis 8.9.4 Company 9 Business Overview/Recent Development/Acquisitions 8.10 Company 10 8.10.1 Company 10 Profile 8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023 8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis 8.10.4 Company 10 Business Overview/Recent Development/Acquisitions 8.11 Company 11 8.11.1 Company 11 Profile 8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023 8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis 8.11.4 Company 11 Business Overview/Recent Development/Acquisitions 8.12 Company 12 8.12.1 Company 12 Profile 8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023 8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis 8.12.4 Company 12 Business Overview/Recent Development/Acquisitions 8.13 Company 13 8.13.1 Company 13 Profile 8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023 8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis 8.13.4 Company 13 Business Overview/Recent Development/Acquisitions 8.14 Company 14 8.14.1 Company 14 Profile 8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023 8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis 8.14.4 Company 14 Business Overview/Recent Development/Acquisitions 8.15 Company 15 8.15.1 Company 15 Profile 8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023 8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis 8.15.4 Company 15 Business Overview/Recent Development/Acquisitions 9 Global Anti-dementia Drugs Market-Segmentation by Geography 10 North America 10.1 North America Anti-dementia Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 10.2 North America Anti-dementia Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 10.3 North America Anti-dementia Drugs Production Analysis from 2017-2023 10.4 North America Anti-dementia Drugs Consumption Analysis from 2017-2023 10.5 North America Anti-dementia Drugs Import and Export from 2017-2023 10.6 North America Anti-dementia Drugs Value, Production and Market Share by Type (2017-2023) 10.7 North America Anti-dementia Drugs Consumption, Value and Market Share by Application (2017-2023) 10.8 North America Anti-dementia Drugs by Country (United States, Canada) 10.8.1 North America Anti-dementia Drugs Sales by Country (2017-2023) 10.8.2 North America Anti-dementia Drugs Consumption Value by Country (2017-2023) 10.9 North America Anti-dementia Drugs Market PEST Analysis 11 Europe 11.1 Europe Anti-dementia Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 11.2 Europe Anti-dementia Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 11.3 Europe Anti-dementia Drugs Production Analysis from 2017-2023 11.4 Europe Anti-dementia Drugs Consumption Analysis from 2017-2023 11.5 Europe Anti-dementia Drugs Import and Export from 2017-2023 11.6 Europe Anti-dementia Drugs Value, Production and Market Share by Type (2017-2023) 11.7 Europe Anti-dementia Drugs Consumption, Value and Market Share by Application (2017-2023) 11.8 Europe Anti-dementia Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Anti-dementia Drugs Sales by Country (2017-2023) 11.8.2 Europe Anti-dementia Drugs Consumption Value by Country (2017-2023) 11.9 Europe Anti-dementia Drugs Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Anti-dementia Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 12.2 Asia-Pacific Anti-dementia Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 12.3 Asia-Pacific Anti-dementia Drugs Production Analysis from 2017-2023 12.4 Asia-Pacific Anti-dementia Drugs Consumption Analysis from 2017-2023 12.5 Asia-Pacific Anti-dementia Drugs Import and Export from 2017-2023 12.6 Asia-Pacific Anti-dementia Drugs Value, Production and Market Share by Type (2017-2023) 12.7 Asia-Pacific Anti-dementia Drugs Consumption, Value and Market Share by Application (2017-2023) 12.8 Asia-Pacific Anti-dementia Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Anti-dementia Drugs Sales by Country (2017-2023) 12.8.2 Asia-Pacific Anti-dementia Drugs Consumption Value by Country (2017-2023) 12.9 Asia-Pacific Anti-dementia Drugs Market PEST Analysis 13 Latin America 13.1 Latin America Anti-dementia Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 13.2 Latin America Anti-dementia Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 13.3 Latin America Anti-dementia Drugs Production Analysis from 2017-2023 13.4 Latin America Anti-dementia Drugs Consumption Analysis from 2017-2023 13.5 Latin America Anti-dementia Drugs Import and Export from 2017-2023 13.6 Latin America Anti-dementia Drugs Value, Production and Market Share by Type (2017-2023) 13.7 Latin America Anti-dementia Drugs Consumption, Value and Market Share by Application (2017-2023) 13.8 Latin America Anti-dementia Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Anti-dementia Drugs Sales by Country (2017-2023) 13.8.2 Latin America Anti-dementia Drugs Consumption Value by Country (2017-2023) 13.9 Latin America Anti-dementia Drugs Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Anti-dementia Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 14.2 Middle East & Africa Anti-dementia Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 14.3 Middle East & Africa Anti-dementia Drugs Production Analysis from 2017-2023 14.4 Middle East & Africa Anti-dementia Drugs Consumption Analysis from 2017-2023 14.5 Middle East & Africa Anti-dementia Drugs Import and Export from 2017-2023 14.6 Middle East & Africa Anti-dementia Drugs Value, Production and Market Share by Type (2017-2023) 14.7 Middle East & Africa Anti-dementia Drugs Consumption, Value and Market Share by Application (2017-2023) 14.8 Middle East & Africa Anti-dementia Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Anti-dementia Drugs Sales by Country (2017-2023) 14.8.2 Middle East & Africa Anti-dementia Drugs Consumption Value by Country (2017-2023) 14.9 Middle East & Africa Anti-dementia Drugs Market PEST Analysis 15 Future Forecast of the Global Anti-dementia Drugs Market from 2023-2029 15.1 Future Forecast of the Global Anti-dementia Drugs Market from 2023-2029 Segment by Region 15.2 Global Anti-dementia Drugs Production and Growth Rate Forecast by Type (2023-2029) 15.3 Global Anti-dementia Drugs Consumption and Growth Rate Forecast by Application (2023-2029) 16 Appendix 16.1 Methodology 16.2 Research Data Source